2025-11-12T00:00:00-0500

2025-11-13T00:00:00-0500

Private Equity Boston Forum Boston | November 12-13, 2025 Request Agenda


The Private Equity Boston Forum is the premier New England event designed to enhance financial and investment practices while fostering collaboration within the private equity community.  

Join us at the Private Equity Boston Event for expert-led panels on key industry topics. Gain insights into developing tailored exit strategies based on market conditions, mastering competitive deal sourcing, and optimizing GP-led transactions and continuation funds 

The event will assemble investors, fund managers, and advisors, offering an ideal platform for exchanging ideas and learning from industry leaders. Throughout the day, our speakers will delve into operational excellence, the changing regulatory environment, and effective strategies for growth and diligence. Learn from top professionals how to maximize value, address risks, and enhance liquidity solutions.

Don’t miss out—sign up now to secure your spot and connect with industry leaders.


banner


CPE banner

SERIES KEYNOTE

John Maldonado, Managing Partner, Advent International

John Maldonado joined Advent in 2006 focusing on buyouts in the healthcare, financial and business services sectors. His previous private equity experience includes positions at both Bain Capital and Parthenon Capital. John began his career as a Consultant with The Parthenon Group, a leading strategy consulting firm.

John earned a BA, summa cum laude, from Dartmouth College and an MBA, with high distinction, as a Baker Scholar from Harvard Business School. 

During his career, John has worked on 27 investments, 22 during his time at Advent, including Bharat Serums and Vaccines, Cotiviti, Definitive Healthcare, Genoa Healthcare, Iodine Software, Simtra BioPharma Solutions, and Suven Pharmaceuticals.

Directorships

Current: AccentCare, Iodine Software, RxBenefits, Simtra BioPharma Solutions.

Previous: American Radiology Services, ATI Physical Therapy, Cotiviti, Definitive Healthcare, Genoa Healthcare, Health Care Private Equity Association, Managed Healthcare Associates, Skillsoft, Syneos, Vantiv (formerly Fifth Third Processing)

Chris Gaffney, Co-Founder and Managing Director, Great Hill Partners

Chris Gaffney is Co-Founder and Managing Director of Great Hill Partners, where he is responsible for investment policy, investor relations and the general management of the firm. Chris is also a member of the firm’s executive and investment committees. Throughout the course of his over 37-year career in private equity, Chris has participated in investments covering a range of industries, including software, robotics and AI, information services, e-commerce, consumer and online services, financial technology, digital publishing, among others. Chris has served on over 50 boards from early-stage companies to publicly traded businesses with multiple investments grown from seed stage to unicorn status.

Jack McCarthy, Managing Partner and Founder, Alvarez & Marsal Capital

Jack McCarthy is a Managing Partner and Founder of Alvarez & Marsal Capital. He is responsible for all aspects of A&M Capital’s business and sits on the Investment and Valuation Committees for all the firm’s investment strategies. Mr. McCarthy currently serves on the board of A&M Capital’s investments in BrightPet Nutrition, GS Foods, PetWise, The Arcticom Group, and VTG, and is a board observer at ProAmpac. Mr. McCarthy has over 30 years of experience private equity investing and operational experience. Before founding A&M Capital, he was a Managing Director, Founder and Co-National Practice Leader of Alvarez & Marsal’s Private Equity Advisory Group, which serves both private equity sponsors and select strategic investors. Prior to that, Mr. McCarthy was a Partner of BA Capital Partners Europe, Bank of America’s European focused middle-market private equity partnership. 

John M. Toomey, Jr, Chief Executive Officer, HarbourVest Partners

John Toomey is the Chief Executive Officer (CEO) of HarbourVest Partners and has served in that capacity since October 1, 2024. He is based at the Firm’s headquarters in Boston.

Prior to his appointment as CEO, John served on the Executive Management Committee (EMC), which led the firm, since 2012. He joined the firm in 1997 as an Analyst in the Direct team and spent ten years as one of the leaders of the Secondary business before serving on Global Investment Committees for nearly a decade. He was also involved in the 2007 IPO of HarbourVest Global Private Equity on Euronext Amsterdam for which he served as the original Chief Financial Officer.

John is a member of the Firm’s Portfolio Construction Committee, Conflicts Committee, ESG Council and DEI Council.

He received a BA (cum laude) in Chemistry and Physics from Harvard University in 1995 and an MBA from Harvard Business School in 2001, where he was awarded the Loeb Fellowship for outstanding achievement in finance.

John Hatherly, Founder, Managing Partner, Wynnchurch Capital

John Hatherly founded Wynnchurch Capital in 1999. Prior to Wynnchurch, he enjoyed a twelve-year career as a senior executive at GE Capital’s Merchant Banking Group. Before GE Capital, John spent three years in banking with the First National Bank of Chicago and BankOne. John has played a lead role in more than 250 investments totaling over $15 billion over his 30-plus-year investment career, including acquisitions, buyouts, recapitalizations, project financing and leasing.


PLATINUM SPONSORS

GOLD SPONSORS

SILVER SPONSORS

BRONZE SPONSOR

INDUSTRY PARTNERS

ENGAGEMENT APP SPONSOR

REQUEST AGENDA

Please note only corporate email addresses will be accepted.

Why do I need to enter my corporate email address?
By using your corporate email address, we can verify that you are a registered financial professional.

Key Discussion Topics

The Future of U.S. Private Equity: Opportunities and Challenges

This panel will delve into the evolving U.S. private equity market, highlighting key trends, opportunities, and challenges. Experts will discuss the factors influencing investment decisions, such as economic conditions, sector performance, and regulatory changes. Panelists will also explore strategies for sourcing deals, evaluating investments, and managing portfolios in a dynamic market.

Private Equity Healthcare Investments in 2025

As we look to 2026, healthcare continues to emerge as a resilient sector amidst economic uncertainty and inflationary pressures. This discussion explores the evolving landscape of private equity in healthcare, highlighting opportunities across key subsectors like biopharma, medtech, diagnostics, and healthcare IT. Industry experts will analyze which are as promise the highest returns and share insights into the challenges and trends shaping healthcare investments in the coming year.


Navigating Expectations in ESG and Impact Investing

With ESG now a priority in private equity, firms are integrating it into due diligence and strategy. This session explores how GPs are addressing LP demands, driving meaningful change, and delivering strong financial returns. Experts will discuss the evolving relationship between sustainability practices and performance, offering actionable insights for navigating growing ESG expectations.

Unlocking Value in Secondaries and Co-Investments

In 2025, private equity investors are increasingly leveraging secondaries, co-investments, continuation funds, and funds of funds to optimize returns. Experts will explore the unique advantages these strategies offer over traditional manager selection in today’s market landscape.


REGISTRATION

INVESTORS: Complimentary Registration for all qualified investors. Email [email protected] for more information on obtaining a complimentary ticket.

MANAGERS & SERVICE PROVIDERS: Rates below reflect the current price for all asset managers and service providers.

PRICING

Event Registration - Managers ONLY 5,000.00 USD 11/14/25

VENUE


Harvard Club of Boston
374 Commonwealth Ave
Boston, MA
United States 02215
CLICK TO VISIT VENUE WEBSITE

CONTACT

Sponsorship Opportunities & Registration

+1 212-804-6220

[email protected]

Allocator Attendance

+1 347-778-2568

[email protected]

Media Partnerships

+1 212-600-8631

[email protected]